Challenging exchange rate makes Novozymes downgrade guidance
Danish enzyme producer Novozymes exits this year's second quarter slightly weaker than expected and is now downgrading its full-year guidance in DKK. Meanwhile, Bioenergy shows growth.
Novozymes emerged from this year's second quarter slightly weaker than expected by analysts, and the company is now downgrading its forecast for sales growth in Danish currency from 3-6 percent to 1-4 percent.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novozymes may be headed towards new generation of executives
For subscribers
Novozymes parts ways with CFO Benny Loft
For subscribers
Novozymes expands enzyme factory for biofuel in the US
For subscribers
.jpg&w=384&q=75)
